Back to results
US 12,582,647 B2Granted
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
AssigneePurdue Pharma L.P.
InventorsMichele Hummel, Donald J. Kyle, Garth Whiteside
Life of this patent
Estimating the term…
Abstract
Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
Claims14
A method of treating or preventing an opioid-induced adverse pharmacodynamic response in a patient identified in need thereof, comprising concurrently administering to the patient
- (i) an analgesically effective amount of oxycodone or a pharmaceutically acceptable salt thereof, and
- (ii) an effective amount of buprenorphine or a pharmaceutically acceptable salt thereof to treat or prevent said adverse pharmacodynamic response in the patient,
- Wherein the administration of buprenorphine or pharmaceutically acceptable salt thereof does not attenuate analgesic effects produced by said oxycodone or pharmaceutically acceptable salt thereof;
- wherein the patient is on a chronic opioid therapy or an opioid naïve patient.
1 more element
Dependencies are inferred from the claim text.